Ticker Hub
COLL — AI Analysis & Sentiment
3 recent AI-generated analyses for COLL. Sentiment and confidence insights updated continuously.
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
Collegium reported robust Q1 results driven by strong JORNAY PM growth and reaffirmed full-year guidance, suggesting continued operational momentum...
May 7, 2026Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
Collegium's acquisition of AZSTARYS, while strategically adding to its ADHD portfolio, significantly increases financial risk due to the high purch...
Mar 19, 2026Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Collegium Pharmaceutical announced a partnership with Paris Hilton to promote ADHD awareness. This partnership could enhance the company's visibili...
Mar 3, 2026